CD8A and acute myeloid leukemia: This analysis suggested a lower abundance of CD8+ T cells in KMT2A::ELL AML compared to KMT2A::MLLT3 AML (P = 0.044; Fig. S1B, C), although the small sample size precluded firm conclusions.